pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
🐶
home
jobs
news
search
HORIZON · news · pharmadog
← back to HORIZON
News mentioning HORIZON
37
stories
5h
Sionna says good-bye to 46% of staffers, including exec
biospace
11h
Exercise — and echocardiograms — in space protected astronauts’ hearts in study
stat
1d
The GOP’s $50 billion rural health fund is coming up short, hospital leaders say
stat
5d
Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
biopharma dive
7d
Novartis’ $12B Avidity acquisition hits Phase 3 speedbump as dystrophy drug disappoints
biospace
7d
Novartis’ cholesterol-lowering medicine fails Phase 3, clouding Lp(a) horizons
biospace
10d
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
stat
10d
Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
fiercebiotech
13d
Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical models
biospace
20d
Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh
biospace
Aug 11, 26
Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths
stat
Jul 31, 26
Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise
biospace
Jul 30, 26
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
biopharma dive
Jul 30, 26
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
fiercebiotech
Jul 29, 26
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
Jul 28, 26
An eye drug biotech banks $118M and stocks its executive suite
biopharma dive
Jul 24, 26
Amgen sheds around 40 staffers amid continuing struggles
fiercebiotech
Jul 22, 26
US ‘eroding’ lead in rare diseases a matter of national security: Report
biospace
Jul 22, 26
As Maui recovers from devastating fires, a study offers vision for new rural health model
stat
Jul 20, 26
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
Jul 16, 26
Chutes & Ladders—Cue lines up new CMO and research head
fiercebiotech
Jul 15, 26
What to know about the parasitic diarrhea outbreak
stat
Jul 14, 26
The risk of refusing a newborn’s vitamin K shot
stat
Jul 13, 26
Caregivers brace for pay cuts, and maybe homelessness
stat
Jul 10, 26
FDA quietly pushes back deadline on electric shock ban
stat
Jul 9, 26
Who’s going to run the FDA?
stat
Jul 8, 26
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
Jul 8, 26
Another big premium hike on the horizon
stat
Jul 7, 26
Ebola outbreak exposes a fractured outbreak response system
stat
Jul 7, 26
STAT+: This whistleblower took on a health insurance giant and a political machine. She’s not stopping there
stat
← prev
page 1 of 2
next →
